Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke
Gregg C. Fonarow(UCLA Medical Center), Lee H. Schwamm(Yale University), Eric E. Smith(University of Calgary), DaiWai M. Olson(Nanotherapeutics (United States)), Mathew J. Reeves(Michigan State University), Deepak L. Bhatt(Mount Sinai Hospital), Eric D. Peterson(The University of Texas Southwestern Medical Center), Jeffrey L. Saver(University of California, Los Angeles), Maria V. Grau‐Sepulveda(Duke University), Adrian F. Hernandez(Duke University)
Cited by 576
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k